Duty to recontact in genomic cancer care: A tool helping to assess the professional’s responsibility
European Journal of Cancer · 2023
DOI: 10.1016/j.ejca.2023.03.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Martine C Ploem und 4 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Faculty of Law, University of Amsterdam, Amsterdam, the Net…. Hauptthemen laut MEDLINE: Duty to Recontact, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ZonMw.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Tumour DNA and germline testing, based on DNA-wide sequencing analysis, are becoming more and more routine in clinical-oncology practice. A promising step in medicine, but at the same time leading to challenging ethicolegal questions. An important one is under what conditions individuals (patients and their relatives, research participants) should be recontacted with new information, even if many years have passed since the last contact. Based on legal- and ethical study, we developed a tool to help professionals to decide whether or not to recontact an individual in specific cases. It is based on four assessment criteria: (1) professional relationship (2) clinical impact (3) individual's preferences and (4) feasibility. The tool could also serve as a framework for guidelines on the topic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Faculty of Law, University of Amsterdam, Amsterdam, the Netherlands.
- Department of Genetics, University Medical Center Utrecht, the Netherlands; Department of Clinical Genetics, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
- Department of Genetics, University Medical Center Utrecht, the Netherlands; Erasmus School of Philosophy, Erasmus University Rotterdam, Rotterdam, the Netherlands.
- Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Erasmus School of Health Policy and Management, Erasmus University Rotter…
- Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Department of Health Technology and Services Research, University Twente,…
Förderung
- ZonMw
Zitieren
APA
Ploem, M. C., Giesbertz, N. A. A., Bredenoord, A. L., Retèl, V. P., & van Harten, W. H. (2023). Duty to recontact in genomic cancer care: A tool helping to assess the professional’s responsibility. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.03.004
Vancouver
Ploem MC, Giesbertz NAA, Bredenoord AL, Retèl VP, van Harten WH. Duty to recontact in genomic cancer care: A tool helping to assess the professional’s responsibility. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.03.004
BibTeX
@article{Ploem2023,
author = {Ploem, Martine C and Giesbertz, Noor A A and Bredenoord, Annelien L and Retèl, Valesca P and van Harten, Wim H},
title = {Duty to recontact in genomic cancer care: A tool helping to assess the professional’s responsibility},
journal = {European Journal of Cancer},
year = {2023},
doi = {10.1016/j.ejca.2023.03.004}
}
EUVIMED